Topography of Protein Kinase C ßII in Benign and Malignant Melanocytic Lesions.
Int J Surg Pathol
; 25(6): 497-501, 2017 Sep.
Article
em En
| MEDLINE
| ID: mdl-28436290
ABSTRACT
BACKGROUND:
Protein kinase C ßII promotes melanogenesis and affects proliferation of melanocytic cells but is frequently absent or decreased in melanoma cells in vitro.OBJECTIVE:
To investigate PKC-ßII expression and spatial distribution within a lesion in various benign and malignant melanocytic proliferations.METHODS:
Expression of PKC-ßII was semiquantitatively assessed in the various existing compartments (intraepidermal [not nested], junctional [nested], and dermal) of benign (n = 43) and malignant (n = 28) melanocytic lesions by immunohistochemistry.RESULTS:
Melanocytes in the basal layer of normal skin or in lentigo simplex stained strongly for PKC-ßII. Common nevi lacked completely PKC-ßII. All other lesions expressed variably PKC-ßII, with cutaneous melanoma metastases displaying the lowest rate of positivity (14%). In the topographical analysis within a lesion, PKC-ßII expression was largely retained in the intraepidermal and junctional part of all other lesions (dysplastic nevus, lentigo maligna, and melanoma). Reduced expression of PKC-ßII was found in the dermal component of benign and malignant lesions ( P = .041 vs intraepidermal). PKC-ßII expression in the various compartments did not differ significantly between benign and malignant lesions.CONCLUSIONS:
The current study revealed a significant correlation between PKC-ßII expression and spatial localization of melanocytes, with the lowest expression found in the dermal compartment and the highest in the epidermal compartment.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Cutâneas
/
Biomarcadores Tumorais
/
Proteína Quinase C beta
/
Melanoma
/
Nevo Pigmentado
Limite:
Humans
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article